We have located links that may give you full text access.
Radiation therapy of recurrent nasopharyngeal carcinoma. Report on 219 patients.
Recurrent nasopharyngeal carcinoma (NPC), if left untreated, has a 5-year survival of less than one per cent. In contrast, the overall 5-year survival in a treated series of patients was 18 per cent. Excluding those with distant metastases at the beginning of the retreatment, the 5-year survival was 23 per cent. If the recurrence was limited to the neck, a 5-year survival of 34 per cent was obtained and if it was confined to the nasopharynx the 5-year survival was 25 per cent. High doses (about 60 Gy), using multiple narrow beams, carefully directed, were required. For recurrences in the neck, lymph node dissection supplemented by a lower radiation dose should be considered. Surgery was sometimes the only possible method for cure, when recurrence occurred in the neck nodes. Recurrences in the neck, especially when repeatedly appearing, most often were combined with a local recurrence in the nasopharynx.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app